HMGCR and prostate carcinoma: Given that HMGCR is highly expressed in most cancers and exhibits distinct prognostic significance across different cancer types, it can serve as a predictive marker and novel therapeutic target for specific tumors with markedly increased cholesterol synthesis, such as prostate cancer, gastric cancer, colorectal cancer, and breast cancer.